ANG and COVID-19: This suggests that in COVID-19 patients the ACE2-independent pathway of peptide generation is efficient to trigger Ang-(1-7) biosynthesis from Ang I when the Ang-(1-7) production through Ang II cleavage by ACE2 is impaired.